Breast Cancer Screening Solutions
Digital mammography and breast cancer early detection software
Company profile
Company profile
MeVis Medical Solutions AG is a leading software company specializing in image-based medicine and medical imaging analysis. The company makes an important contribution to the early detection and diagnosis of cancer diseases, enabling timely and appropriate therapy. MeVis develops innovative software for the analysis and evaluation of imaging data and markets these solutions to manufacturers of medical devices and providers of medical IT platforms. The company's competence is based on many years of technological experience and close proximity to end users. MeVis accompanies its industrial customers from the initial product idea through application development, integration into customer-specific platforms, and sustainable quality assurance. The company's clinical focus areas include image-based early detection and diagnosis of epidemiologically significant diseases such as breast, lung, and liver cancer, as well as neurological diseases. MeVis also creates technical visualizations used in continuing education, presentations, and research purposes. The company's software applications support all applicable imaging modalities, including magnetic resonance imaging, digital mammography, computed tomography, tomosynthesis, and ultrasound-based digital sonography. MeVis offers its Veolity portfolio of solutions that support radiologists, screening centers, and national screening initiatives throughout the workflow, particularly for lung cancer screening programs in Europe.
Company description MeVis Medical Solutions official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Other deployment with recorded integration context.
Recorded integration context: Hologic medical imaging systems, Medical device manufacturer platforms, Medical IT platforms.
Company milestones
Presenting Veolity portfolio at ESTI 2026 in Salzburg (June 2026) for lung cancer screening solutions; Former joint venture MeVis Breast Care GmbH & Co. KG integrated into main company; Expansion into lung cancer screening market in Europe
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Digital mammography and breast cancer early detection software
Image analysis software for liver cancer detection and assessment
Software for neurological disease diagnosis and visualization
Lung cancer screening workflow solutions for radiologists and screening centers
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
International journal of computer assisted radiology and surgery · Jan 1, 2025
Enhancing Perioperative Outcomes of Pancreatic Surgery with Wearable Augmented Reality Assistance System: A Matched-Pair Analysis.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · Dec 1, 2024
Using AI and Gd-EOB-DTPA-enhanced MR imaging to assess liver function, comparing the MELIF score with the ALBI score.Scientific reports · Aug 12, 2023
MELIF, a Fully Automated Liver Function Score Calculated from Gd-EOB-DTPA-Enhanced MR Images: Diagnostic Performance vs. the MELD Score.Diagnostics (Basel, Switzerland) · Jul 20, 2022
Learning-based three-dimensional registration with weak bounding box supervision.Journal of medical imaging (Bellingham, Wash.) · Jul 1, 2022
Assessment of Liver Function With MRI: Where Do We Stand?Frontiers in medicine · Jan 1, 2022
Clinical validation
No linked records are currently available.
Regulatory
K232045 · 510k · Oct 27, 2023
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Enables early detection and diagnosis of cancer diseases for timely therapy
Integration of mammography software solutions for breast cancer screening
05 · Leadership
Leadership profiles and professional links from the current Company record.
Marcus Kirchhoff
CEO
Matthew A. Martinez
Chairman of the Supervisory Board
06 · Company updates
Recent articles published on MeVis Medical Solutions's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.